|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000132000 |
Summary for PODNL1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000132000 | Gene symbol | PODNL1 |
| Gene name | podocan like 1 | |
| HGNC | 26275 | |
| Entrez ID | 79883 | |
| Gene type | protein_coding | |
| Synonyms | PODNL1|FLJ23447|SLRR5B | |
| UniProtAcc | Q6PEZ8 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PODNL1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PODNL1 | 3.92e+02 | 2.03e+00 | 5.13e-01 | 3.95e+00 | 7.75e-05 | 3.55e-04 | BLCA |
| PODNL1 | 8.34e+02 | 1.74e+00 | 5.15e-01 | 3.38e+00 | 7.17e-04 | 4.86e-03 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PODNL1 | 6.76e+02 | 1.07e+00 | 2.88e-01 | 3.72e+00 | 2.02e-04 | 1.07e-03 | HNSC |
| PODNL1 | 2.77e+02 | 2.41e+00 | 4.33e-01 | 5.56e+00 | 2.73e-08 | 3.78e-07 | READ |
Top |
Sex-biased somatic mutation for PODNL1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PODNL1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg10760452 | chr19:13953776 | CGI:chr19:13951973-13952791 | promoter | 7.88e-01 | 6.88e-01 | 4.71e+00 | 2.52e-06 | 4.50e-06 | 1.00e-01 |
| BRCA | cg25264101 | chr19:13953562 | CGI:chr19:13951973-13952791 | promoter | 4.90e-01 | 3.34e-01 | 9.96e+00 | 2.21e-23 | 1.61e-22 | 1.56e-01 |
| HNSC | cg26969888 | chr19:13953442 | CGI:chr19:13951973-13952791 | promoter | 2.40e-01 | 1.39e-01 | 2.50e+00 | 1.24e-02 | 2.09e-02 | 1.01e-01 |
| HNSC | cg25264101 | chr19:13953562 | CGI:chr19:13951973-13952791 | promoter | 3.99e-01 | 2.98e-01 | 2.38e+00 | 1.75e-02 | 2.55e-02 | 1.01e-01 |
| KIRP | cg26969888 | chr19:13953442 | CGI:chr19:13951973-13952791 | promoter | 2.95e-01 | 1.84e-01 | 2.15e+00 | 3.13e-02 | 3.63e-02 | 1.10e-01 |
Top |
Exon skipping events with PSI in TCGA for PODNL1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PODNL1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| SKCM | PODNL1-013 | chr19_13949445_- | 2.13e-01 | 1.40e-01 | 2.40e+00 | 1.64e-02 | 4.90e-02 | 7.25e-02 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PODNL1 |
| TFs related to PODNL1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PODNL1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PODNL1 |
| RBPs related to ES in PODNL1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PODNL1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000132000 | AC016877.3,hsa-mir-338,PODNL1 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000132000 | ITGB2-AS1,hsa-mir-338,PODNL1 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000132000 | AC016026.1,hsa-mir-338,PODNL1 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000132000 | AC108134.3,hsa-mir-431,PODNL1 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000132000 | AC025048.4,hsa-mir-431,PODNL1 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000132000 | AC016026.1,hsa-mir-431,PODNL1 | Female-specific ceRNA | TCGA-KICH |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs113737643 | chr19:12193739:A:T | - | 0.455549567864798 | 6.28375056111064e-06 | GBM | Female-baised eQTL |
| rs8104674 | chr19:12258691:G:A | - | 0.393263540160833 | 0.0127607769158543 | GBM | Female-baised eQTL |
| rs34009421 | chr19:12292895:C:T | - | 0.393263540160833 | 0.0127607769158543 | GBM | Female-baised eQTL |
| rs12165117 | chr19:20662785:G:A | - | 0.0783152651657018 | 0.0331237881910115 | COAD | Female-baised eQTL |
| rs12165116 | chr19:20662875:A:G | - | 0.0783152651657018 | 0.0331237881910115 | COAD | Female-baised eQTL |
| rs74720709 | chr19:10985034:T:C | - | 0.0770887595922781 | 0.0347007227758214 | COAD | Female-baised eQTL |
| rs78732262 | chr19:10985220:T:C | - | 0.0770887595922781 | 0.0347007227758214 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11086022 | chr19:16075220:G:A | - | 0.0458179569265695 | 0.0414359437001551 | HNSC | Male-baised eQTL |
| rs10418402 | chr19:16074609:G:T | - | 0.0453731379383891 | 0.0438026905236226 | HNSC | Male-baised eQTL |
| rs8113101 | chr19:16075655:G:T | - | 0.0455186772768829 | 0.046417525107638 | HNSC | Male-baised eQTL |
| rs73003793 | chr19:16073999:G:C | - | 0.0449697799423218 | 0.0485376477112128 | HNSC | Male-baised eQTL |
| rs10414221 | chr19:16074378:C:G | - | 0.0449697799423218 | 0.0485376477112128 | HNSC | Male-baised eQTL |
| rs10426103 | chr19:16074561:T:C | - | 0.0449697799423218 | 0.0485376477112128 | HNSC | Male-baised eQTL |
| rs12462208 | chr19:5543891:A:G | - | 0.135228399899522 | 0.00593738971132683 | SARC | Male-baised eQTL |
| rs8102322 | chr19:16978210:G:C | - | 0.111439283463364 | 0.0137117093525903 | SARC | Male-baised eQTL |
| rs17304401 | chr19:5495186:G:C | - | 0.108990239398535 | 0.0402987818893371 | SARC | Male-baised eQTL |
| rs73013012 | chr19:10133878:G:A | - | 0.139383564635465 | 0.00050639417460976 | COAD | Male-baised eQTL |
| rs73502593 | chr19:17045602:A:G | - | 0.113625172528188 | 0.000520811780709723 | COAD | Male-baised eQTL |
| rs138341216 | chr19:10123934:G:C | - | 0.138833599910536 | 0.000550736853608355 | COAD | Male-baised eQTL |
| rs2228613 | chr19:10154917:G:T | - | 0.127012430825956 | 0.00207749987120899 | COAD | Male-baised eQTL |
| rs142630834 | chr19:10160847:A:G | - | 0.127012430825956 | 0.00207749987120899 | COAD | Male-baised eQTL |
| rs146278326 | chr19:10164508:G:A | - | 0.127012430825956 | 0.00207749987120899 | COAD | Male-baised eQTL |
| rs117070319 | chr19:18656784:A:G | - | 0.114519919329736 | 0.0106809263946895 | COAD | Male-baised eQTL |
| rs118150194 | chr19:18655392:G:C | - | 0.114020170978729 | 0.0113894073761221 | COAD | Male-baised eQTL |
| rs117009988 | chr19:18636238:G:A | - | 0.105067999969143 | 0.0161095398374846 | COAD | Male-baised eQTL |
| rs79342923 | chr19:10494960:G:T | - | 0.0941894461443891 | 0.0172782171064082 | COAD | Male-baised eQTL |
| rs74598573 | chr19:18635627:G:A | - | 0.0986061913701474 | 0.0186626109348437 | COAD | Male-baised eQTL |
| rs74568449 | chr19:21732108:T:G | - | 0.117292459392406 | 0.0216097642360062 | COAD | Male-baised eQTL |
| rs1912579 | chr19:21799550:A:G | - | 0.114374752431933 | 0.0223873040600625 | COAD | Male-baised eQTL |
| rs76227891 | chr19:21818623:G:A | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs75458430 | chr19:21818912:T:C | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs79720979 | chr19:21819432:T:A | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs76366771 | chr19:21827523:G:A | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs111446979 | chr19:21827730:C:T | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs146565576 | chr19:21833369:C:T | - | 0.118184749295077 | 0.0225947943446036 | COAD | Male-baised eQTL |
| rs75897063 | chr19:21843662:G:A | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs75162832 | chr19:21844236:C:T | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs78487711 | chr19:21846754:G:T | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs76943102 | chr19:21850628:T:C | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs78138759 | chr19:21851172:A:G | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs76875532 | chr19:21853597:G:C | - | 0.118055693550061 | 0.0229375314538347 | COAD | Male-baised eQTL |
| rs295385 | chr19:23347215:T:A | - | -0.0620255273449125 | 0.0237864913541602 | COAD | Male-baised eQTL |
| rs295411 | chr19:23328191:A:T | - | -0.0612162261914273 | 0.0266828206092597 | COAD | Male-baised eQTL |
| rs295393 | chr19:23345060:T:C | - | -0.0612162261914273 | 0.0266828206092597 | COAD | Male-baised eQTL |
| rs10405228 | chr19:21775242:G:A | - | 0.120354208972381 | 0.0278770815579307 | COAD | Male-baised eQTL |
| rs874492 | chr19:7767115:A:T | - | 0.0569777569601046 | 0.0278941593153435 | COAD | Male-baised eQTL |
| rs113837245 | chr19:21704915:A:G | - | 0.115817989998949 | 0.027962709167325 | COAD | Male-baised eQTL |
| rs295390 | chr19:23345548:T:C | - | -0.0608653425852341 | 0.0284521727879424 | COAD | Male-baised eQTL |
| rs12973739 | chr19:23316980:A:G | - | -0.0612805423997373 | 0.0285743392658594 | COAD | Male-baised eQTL |
| rs2434383 | chr19:23320643:G:T | - | -0.0612805423997373 | 0.0285743392658594 | COAD | Male-baised eQTL |
| rs12984965 | chr19:23324885:C:T | - | -0.0612805423997373 | 0.0285743392658594 | COAD | Male-baised eQTL |
| rs607168 | chr19:23459336:A:C | - | -0.0571788411471552 | 0.0287089187594737 | COAD | Male-baised eQTL |
| rs295383 | chr19:23348402:A:G | - | -0.0612798751787846 | 0.0288965210242149 | COAD | Male-baised eQTL |
| rs112543804 | chr19:21704889:C:T | - | 0.113502307671141 | 0.0301599333052636 | COAD | Male-baised eQTL |
| rs295416 | chr19:23326030:G:A | - | -0.0600935352104358 | 0.0315838834300893 | COAD | Male-baised eQTL |
| rs295408 | chr19:23329478:G:A | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs295407 | chr19:23330872:C:T | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs295404 | chr19:23333615:G:C | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs295403 | chr19:23334244:A:G | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs295402 | chr19:23334765:A:G | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs295401 | chr19:23335026:T:C | - | -0.0604518174251566 | 0.0323268658159277 | COAD | Male-baised eQTL |
| rs4505459 | chr19:21732685:C:T | - | 0.115493218835729 | 0.0324094531896108 | COAD | Male-baised eQTL |
| rs2633336 | chr19:16686856:T:C | - | -0.0807981348917149 | 0.0342894124401001 | COAD | Male-baised eQTL |
| rs75671674 | chr19:21715838:G:A | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs114125235 | chr19:21718827:G:C | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs78599900 | chr19:21719418:A:G | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs75191519 | chr19:21722934:A:G | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs79681071 | chr19:21723883:A:C | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs76450366 | chr19:21724367:T:C | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs111540312 | chr19:21734343:G:A | - | 0.110631816037579 | 0.0342966535186603 | COAD | Male-baised eQTL |
| rs4130935 | chr19:21741742:T:C | - | 0.112559696024044 | 0.0364168173249758 | COAD | Male-baised eQTL |
| rs113832044 | chr19:21746919:A:G | - | 0.112559696024044 | 0.0364168173249758 | COAD | Male-baised eQTL |
| rs113522932 | chr19:21760323:T:A | - | 0.112559696024044 | 0.0364168173249758 | COAD | Male-baised eQTL |
| rs78661071 | chr19:21762455:A:G | - | 0.112559696024044 | 0.0364168173249758 | COAD | Male-baised eQTL |
| rs684580 | chr19:23457151:T:C | - | -0.0565137878917937 | 0.0370030839464003 | COAD | Male-baised eQTL |
| rs2619709 | chr19:23453368:T:C | - | -0.0557771471717228 | 0.0390220422866398 | COAD | Male-baised eQTL |
| rs295381 | chr19:23349915:C:T | - | -0.0585618441914326 | 0.04106726124405 | COAD | Male-baised eQTL |
| rs35462958 | chr19:23390177:A:G | - | -0.0575903437164995 | 0.0423970866117832 | COAD | Male-baised eQTL |
| rs3803908 | chr19:4250994:A:G | - | 0.0550568095415567 | 0.0429724672692634 | COAD | Male-baised eQTL |
| rs427567 | chr19:23305998:T:G | - | -0.0582987326202786 | 0.0436725259542432 | COAD | Male-baised eQTL |
| rs1600361 | chr19:23389695:A:T | - | -0.0565225663166015 | 0.0455365339996781 | COAD | Male-baised eQTL |
| rs295353 | chr19:23314647:T:C | - | -0.05770783448577 | 0.0456319352229592 | COAD | Male-baised eQTL |
| rs424223 | chr19:23303091:G:T | - | -0.0578873691339518 | 0.0456631133214205 | COAD | Male-baised eQTL |
| rs71333885 | chr19:23387495:C:T | - | -0.0568921052686398 | 0.0462668337725527 | COAD | Male-baised eQTL |
| rs453711 | chr19:23303979:G:A | - | -0.0576794031993133 | 0.0463492357035656 | COAD | Male-baised eQTL |
| rs2438154 | chr19:23315542:T:C | - | -0.0575436768039786 | 0.0464678577510305 | COAD | Male-baised eQTL |
| rs295380 | chr19:23349923:C:T | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs295379 | chr19:23350749:G:A | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs295370 | chr19:23356960:C:T | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs159356 | chr19:23358198:G:A | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs295368 | chr19:23358670:A:G | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs296092 | chr19:23362202:G:A | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs296086 | chr19:23364220:A:G | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs296085 | chr19:23364245:T:C | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs296081 | chr19:23368440:A:G | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs8104071 | chr19:23372496:C:T | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs8102644 | chr19:23376569:T:C | - | -0.0575485499118186 | 0.046889139820016 | COAD | Male-baised eQTL |
| rs12978950 | chr19:23385626:T:C | - | -0.0568268411070163 | 0.0486363519562876 | COAD | Male-baised eQTL |
| rs113427707 | chr19:21764158:C:T | - | 0.110153275773496 | 0.0489825014532658 | COAD | Male-baised eQTL |
| rs75001417 | chr19:21764975:A:G | - | 0.110153275773496 | 0.0489825014532658 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000132000 |
| CpG Site: cg07425555 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: - | |
| Female Effect: -0.0825016874339096 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg07425555 | chr19:13938205 | gene,exon,UTR | -0.0825016874339096 | 5.23948279750272e-08 | -0.3967652255792756 | 4.8124987015406014e-11 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PODNL1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
